Search - tctmd.com

Displaying 81 - 100 of 303

Sort: Relevancy | Date

Presentation TVT 2023

The Medtronic Intrepid Journey

Presenter: Martin Leon

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation TVT 2023

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Presenter: Amit Vora

June 07, 2023

Presentation Fellows 2023

The Evolution in PCI Pharmacology: What You Need to Know

Presenter: Binita Shah

May 11, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation Miami Valves 2023

Evolution of ICD Therapy: 50 Years of Progress

Presenter: Sanjeev Saksena

February 03, 2023

Presentation Miami Valves 2023

Evolution of the Management of Cardiogenic Shock

Presenter: David A. Baran

February 02, 2023

Presentation TCT 2022

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Presenter: Rohit Masih

September 19, 2022

Presentation TCT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

Presenter: Azeem Latib

September 17, 2022

Presentation TCT 2022

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Presenter: John Forrest

September 17, 2022

Presentation TVT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

June 10, 2022

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Presentation TVT 2022

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Presenter: Andrea Scotti

June 09, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

Presenter: Marc Allard-Ratick

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

Advertisement

The Medtronic Intrepid Journey

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

The Evolution in PCI Pharmacology: What You Need to Know

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Evolution of ICD Therapy: 50 Years of Progress

Evolution of the Management of Cardiogenic Shock

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Patient Selection for PFO Closure in 2022: An Evolutionary Process

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Proven Safety through MitraClip G4 and Evolution of TEER

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content